Key Metrics
CiteScore 

6.4
Impact Factor 

< 5
SNIP 

0.64
Recommended pre-submission checks
Powered by 

CNS and Neurological Disorders - Drug Targets Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS and Neurological Disorders - Drug Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in CNS and Neurological Disorders - Drug Targets
Endothelial-to-mesenchymal Transition at the Blood-brain Barrier: Molecular Mechanisms and Pathological Roles Across Brain Diseases.
- 25 Jul 2026
- CNS & neurological disorders drug targets
Zolpidem vs. Emerging Hypnotics: Neuropsychiatric Effects and Ethical Considerations.
- 16 Jul 2026
- CNS & neurological disorders drug targets
Exosomes in Neurodegenerative Disorders: Isolation Strategies, Therapeutic Potential, and Clinical Trials.
- 14 Jul 2026
- CNS & neurological disorders drug targets
MiR-206-mediated Regulation in Depression: From Pathophysiological Mechanisms to Intranasal AntagomiR-206 Therapy.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Syntaxin-4 at the Crossroads of Synaptic Plasticity and Neurodegeneration: From Molecular Mechanisms to Biomarker and Therapeutic Potential.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Characteristics of Dysphagia Secondary to Ultrasound-guided Botulinum Injections for Cervical Dystonia.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Endothelial-to-mesenchymal Transition at the Blood-brain Barrier: Molecular Mechanisms and Pathological Roles Across Brain Diseases.
- 25 Jul 2026
- CNS & neurological disorders drug targets
Zolpidem vs. Emerging Hypnotics: Neuropsychiatric Effects and Ethical Considerations.
- 16 Jul 2026
- CNS & neurological disorders drug targets
Exosomes in Neurodegenerative Disorders: Isolation Strategies, Therapeutic Potential, and Clinical Trials.
- 14 Jul 2026
- CNS & neurological disorders drug targets
MiR-206-mediated Regulation in Depression: From Pathophysiological Mechanisms to Intranasal AntagomiR-206 Therapy.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Syntaxin-4 at the Crossroads of Synaptic Plasticity and Neurodegeneration: From Molecular Mechanisms to Biomarker and Therapeutic Potential.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Characteristics of Dysphagia Secondary to Ultrasound-guided Botulinum Injections for Cervical Dystonia.
- 8 Jul 2026
- CNS & neurological disorders drug targets
FAQs on CNS and Neurological Disorders - Drug Targets
How long has CNS and Neurological Disorders - Drug Targets been actively publishing? 
What is the publishing frequency of CNS and Neurological Disorders - Drug Targets? 
How many articles did CNS and Neurological Disorders - Drug Targets publish last year? 
What is the eISSN & pISSN for CNS and Neurological Disorders - Drug Targets? 
What is Citescore for CNS and Neurological Disorders - Drug Targets? 
What is SNIP score for CNS and Neurological Disorders - Drug Targets? 
Who is the publisher of CNS and Neurological Disorders - Drug Targets? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary